Calendar Eli Lilly and Company Deutsche Boerse AG

Equities

LLY

US5324571083

Market Closed - Deutsche Boerse AG 16:09:30 16/05/2024 BST 5-day change 1st Jan Change
714.2 EUR -0.78% Intraday chart for Eli Lilly and Company -1.14% +35.65%

Chart calendar Eli Lilly and Company

825f965ef.qPAIxnHm6TTUcudx3qLErkVzo4BA1ZeHbTmJLp-5flI.4Z5vojCNs3K2A6Mypsuc9HAa-s1ymOXUH1rPasmKMh_b3VKUQ6KDXeFEvg~dd16373fce67d811c61fae667432cfff

Upcoming events on Eli Lilly and Company

21/06/2024 20:45 American Diabetes Association Scientific Symposium
08/08/2024 11:25 Q2 2024 Earnings Release
08/08/2024 15:00 Q2 2024 Earnings Call
30/10/2024 10:25 Q3 2024 Earnings Release
30/10/2024 14:00 Q3 2024 Earnings Call
29/01/2025 Q4 2024 Earnings Release (Projected)
23/04/2025 Q1 2025 Earnings Release (Projected)
04/08/2025 Q2 2025 Earnings Release (Projected)
03/11/2025 Q3 2025 Earnings Release (Projected)

Past events on Eli Lilly and Company

06/05/2024 13:30 Annual General Meeting
30/04/2024 15:00 Q1 2024 Earnings Call
30/04/2024 11:45 Q1 2024 Earnings Release
08/04/2024 21:30 American Association for Cancer Research Meeting - Abstract Number: 3230
08/04/2024 21:30 American Association for Cancer Research Meeting - Abstract Number: 3316
08/04/2024 17:00 American Association for Cancer Research Meeting - Abstract Number: 1872
09/03/2024 American Academy of Dermatology Meeting
06/03/2024 14:10 TD Cowen Health Care Conference - Fireside Chat
13/02/2024 Ex-dividend day
06/02/2024 15:00 Q4 2023 Earnings Call
06/02/2024 11:45 Q4 2023 Earnings Release
09/01/2024 22:15 JPMorgan Healthcare Conference
12/12/2023 02:00 American Society of Hematology Meeting - Abstract No:5152
12/12/2023 01:00 American Society of Hematology Meeting - Abstract No:981
11/12/2023 02:00 American Society of Hematology Meeting - Abstract No:3269
11/12/2023 02:00 American Society of Hematology Meeting - Abstract No:3626
11/12/2023 02:00 American Society of Hematology Meeting - Abstract No:3026
10/12/2023 01:30 American Society of Hematology Meeting - Abstract No:1660
10/12/2023 01:30 American Society of Hematology Meeting - Abstract No:1737
10/12/2023 00:15 American Society of Hematology Meeting - Abstract No:326

Past dividends on Eli Lilly and Company

14/05/2024 Quarterly 1.3 USD
13/02/2024 Quarterly 1.3 USD
13/11/2023 Quarterly 1.13 USD
13/08/2023 Quarterly 1.13 USD
11/05/2023 Quarterly 1.13 USD
13/02/2023 Quarterly 1.13 USD
13/11/2022 Quarterly 0.98 USD
11/08/2022 Quarterly 0.98 USD
12/05/2022 Quarterly 0.98 USD
13/02/2022 Quarterly 0.98 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
22 320
22 142
0.8%
24 540
24 394
0.6%
28 318
28 205
0.4%
28 541
28 641
-0.35%
34 124
33 585
1.6%

43 027

EBITDA
Million USD
Released
Forecast
Spread
7 551
7 508
0.57%
8 589
8 676
-1.01%
10 005
9 767
2.43%
9 473
9 494
-0.23%
8 584
8 418
1.98%

16 205

EBIT
Million USD
Released
Forecast
Spread
6 079
6 106
-0.44%
7 265
7 503
-3.17%
8 457
8 599
-1.65%
7 950
8 164
-2.62%
7 057
6 928
1.86%

14 701

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
5 266
8 975
-41.33%
7 230
7 041
2.68%
6 156
7 148
-13.88%
6 806
7 084
-3.93%
6 555
6 311
3.86%

13 737

Net income
Million USD
Released
Forecast
Spread
8 318
8 090
2.83%
6 194
5 805
6.69%
5 582
6 019
-7.27%
6 245
6 102
2.35%
5 240
5 307
-1.26%

11 932

EPS
USD
Released
Forecast
Spread
8,89
8,65
2.83%
6,79
6,36
6.69%
6,12
6,43
-4.75%
6,90
6,60
4.57%
5,80
6,04
-3.92%

13,4

Announcement Date30/01/2029/01/2103/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
7 810
7 319
6.7%
6 488
6 854
-5.33%
6 942
6 901
0.58%
7 302
7 376
-1%
6 960
6 867
1.36%
8 312
7 590
9.51%
9 499
8 965
5.96%
9 353
8 971
4.27%
8 768
8 930
-1.81%

10 024


11 347


12 824


10 745


11 515

EBITDA
Million USD
Released
Forecast
Spread
3 046
2 717
12.12%
1 679
2 387
-29.67%
2 373
2 385
-0.5%
2 375
2 268
4.72%
1 982
2 148
-7.73%
2 618
2 416
8.39%
986
3 460
-71.49%
2 855
3 517
-18.81%
3 049
2 827
7.84%

3 747


4 838


5 994







EBIT
Million USD
Released
Forecast
Spread
2 610
2 336
11.74%
1 330
1 790
-25.7%
2 010
2 007
0.13%
2 000
1 953
2.41%
1 620
1 840
-11.95%
2 252
2 078
8.37%
575
921
-37.56%
2 468
2 448
0.79%
2 648
2 674
-0.96%

3 080


3 976


4 816







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread















2 089
2 107
-0.86%
427
-399
207.07%
2 509
1 248
101.03%
2 536
2 455
3.3%

3 000


3 878


4 497







Net income
Million USD
Released
Forecast
Spread
1 903
1 711
11.22%
953
1 133
-15.93%
1 452
1 453
-0.09%
1 938
1 681
15.27%
1 345
1 544
-12.9%
1 763
1 660
6.22%
-57,4
-813
92.94%
2 190
1 811
20.89%
2 243
2 058
8.99%

2 477


3 249


4 025







EPS
USD
Released
Forecast
Spread



1,05
1,85
-43.24%
1,61
1,90
-15.26%
2,14
1,78
20.22%
1,49
2,04
-26.96%
1,95
1,81
7.73%
-0,06
-0,66
90.91%
2,42
2,26
7%
2,48
2,44
1.64%

2,77


3,60


4,46







Announcement Date28/04/2204/08/2201/11/2202/02/2327/04/2308/08/2302/11/2306/02/2430/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. LLY Stock
  5. Calendar Eli Lilly and Company